XML 81 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net loss $ (26,237) $ (15,169)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,824 1,968
Depreciation 184 171
Non-cash interest expense related to term loan 206 180
Non-cash lease expense 200 190
Loss on disposal of assets 9 41
Change in other, net 116 41
Loss on extinguishment of debt 0 681
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (4,130) (1,692)
Accounts payable 1,490 (266)
Accrued liabilities and other liabilities (1,753) (2,701)
Net cash used in operating activities (27,091) (16,556)
Cash Flows from Investing Activities:    
Capital expenditures (556) (24)
Net cash used in investing activities (556) (24)
Cash Flows from Financing Activities:    
Proceeds from sale of common stock and pre-funded warrants in 2026 private placement 120,000 0
Payments from sale of common stock and pre-funded warrants in 2026 private placement (4,875) 0
Payment of withholding taxes for stock-based compensation (190)
Payments on issuance cost from registration statement 0 (419)
Proceeds from issuance of term loan, net 0 19,688
Repayment of former term loan 0 (10,213)
Payment of loan financing cost 0 (127)
Proceeds from exercise of stock options 6 198
Net cash provided by financing activities 114,941 9,127
Effect of exchange rate changes on cash, cash equivalents and restricted cash (16) (22)
Net (decrease) increase in cash, cash equivalents and restricted cash 87,278 (7,475)
Cash, cash equivalents and restricted cash at the beginning of the period 176,984 168,729
Cash, cash equivalents and restricted cash at the end of the period 264,262 161,254
Supplemental Disclosure of Non-cash Activities    
Conversion of K2 term loan into shares of common stock 941 0
Costs from sale of common stock and pre-funded warrants in 2026 private placement not yet paid 233 0
Deferred offering and share issue costs not yet paid 0 138
Issuance of warrants in connection with term loan agreement 0 524
Supplemental Disclosure of Cash Flow Information    
Cash paid for interest $ 342 $ 311